COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study-Reference-Cited by-同舟云学术

COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

Published:2022-09-22 Issue:10 Volume:6 Page:e780
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Niemann Carsten U.,Awan Farrukh T.,Fogliatto Laura,Nikitin Eugene,Samoilova Olga,Habib Adel,Foroutanpour Kayhan,Kuptsova-Clarkson Nataliya,Opat Stephen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference17 articles.

1. Chronic lymphocytic leukemia-induced humoral immunosuppression: a systematic review.;Grywalska;Cells,2020

2. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.;Chatzikonstantinou;Leukemia,2021

3. Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia.;da Cunha-Bang;Leuk Lymphoma,2022

4. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.;Hallek;Blood,2018

5. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: a meta-analysis.;Du;Nutr Metab Cardiovasc Dis,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of infectious morbidity due to BTK inhibitors in indolent B-cell lymphomas: latest research findings and systematic analysis;Expert Opinion on Pharmacotherapy;2024-07-23

2. Evidence-based expert consensus on clinical management of safety of Bruton's tyrosine kinase inhibitors (2024);CHINESE J CANCER RES;2024

3. Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis;Revista da Associação Médica Brasileira;2024

4. COVID‐19 and cancer: Dichotomy of the menacing dilemma;MedComm – Oncology;2023-11-30